| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $220.7M | +15.4% |
| Cost of Revenue | $107.7M | +10.8% |
| Gross Profit | $113.0M | +20.1% |
| R&D Expense | $116.3M | +4.9% |
| SG&A Expense | $80.1M | -0.9% |
| Operating Income | -$169.7M | +3.4% |
| Interest Expense | $0 | — |
| Pre-tax Income | -$139.7M | +13.3% |
| Income Tax | $815K |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.9M | -53.9% |
| Accounts Receivable | $43.3M | +11.2% |
| Current Assets | $370.2M | -22.2% |
| Total Assets | $702.0M | -6.7% |
| Current Liabilities | $136.6M | +11.8% |
| Total Liabilities | $184.0M | +4.2% |
| Stockholders' Equity | $518.0M | -10.1% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.7M | +31.4% |
| Capital Expenditures | $38.0M | +263.9% |
| Investing Cash Flow | -$33.6M | +86.1% |
| Financing Cash Flow | -$1.6M | -120.3% |
| Free Cash Flow | -$88.7M | -5.1% |
| -3.8% |
| Net Income | -$140.5M | +13.2% |
| EPS (Basic) | -$0.50 | +18.0% |
| EPS (Diluted) | -$0.50 | +18.0% |